Skip to content

Efficacy of Pericapsular Nerve Group (PENG) Block for Hip Surgeries

The Impact of Pericapsular Nerve Group Block on The Duration of Post-Operative Analgesia Following Hip Joint Surgeries

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06144931
Enrollment
38
Registered
2023-11-22
Start date
2023-06-01
Completion date
2024-03-01
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Keywords

PENG, Hip Joint Surgeries, postoperative analgesia

Brief summary

To study the efficacy of the PENG block on the duration of postoperative analgesia. There are two groups of patients, who are undergoing hip joint surgeries, one group (Control Group) will receive spinal anesthesia only while the other group (PENG Group) will receive PENG block before spinal anesthesia.

Detailed description

Research Question: Is PENG block effective in prolonging the duration of postoperative analgesia when compared to patients undergoing spinal anesthesia only? Research Hypothesis: PENG block is effective in prolonging the duration of postoperative analgesia and reducing postoperative pain. Aim: To improve the outcome of hip joint surgeries by decreasing the postoperative pain and early mobilization by performing PENG block to patients undergoing hip joint surgeries. Method of randomization: This clinical trial will be randomized through computer software that generates random number table and patients will be allocated randomly to one of the two groups. Sample size: The sample size was determined by using the following equation:(Charan J et al. 2013) N =(2 δ\^(2 ) 〖(Z\_α+ Z\_β)〗\^2)/D\^2 δ=Standard deviation of the outcome = 6.7 (Pascarella et al., 2021). Z\_α= The value for a type I error of 5% = 1.96 Z\_β=The value for a type II error of 20% = 0.84 D\^2= The effect size = 36 (Pascarella et al., 2021). By calculation: N = 19 per group. So, the total sample size is 38. Procedures: After getting the informed consent from the patient, the patient will be allocated into one of the study groups according to randomization. ASA standard monitors will be attached to the patient, a wide pore cannula (18G) will be inserted then a premedication with 50 -100 mcg of fentanyl and 1-2 mg midazolam intravenously will be given. PENG group: PENG block will done under complete aseptic condition with 20 ml 0.25% bupivacaine diluted with normal saline Control group: no block will be done. Both groups will be anesthetized using spinal anesthesia with Bupivacaine Study Variables: Independent variables: age, sex, weight, height, body mass index (BMI), elective or emergency surgery, duration of surgery, American Society of Anesthesiologists physical status classification (ASA score), occupation, fracture site, type of trauma, timing (operating room entry- PENG block time- start of spinal anesthesia- start of surgery- end of surgery ). Dependent variables: Postoperative pain, adverse events, and postoperative motor assessment, hemodynamics, the first request of analgesia & total analgesia required, adverse events such as nausea vomiting & sedation, pain scores at preparation room, after PENG block, during sitting for spinal anesthesia, at end of the surgery, postoperative intervals(rest & movement).

Interventions

PROCEDUREPENG Block

With the patient in the supine position, the ultrasound probe is placed on a transverse plane over the anterior superior iliac spine (ASIS). Once the ASIS is identified, the transducer is aligned with the pubic ramus and rotated at approximately 45 degrees, parallel to the inguinal crease. The transducer then slides medially along this axis until the anterior inferior iliac spine (AIIS), iliopubic eminence (IPE), and the psoas tendon is clearly identified, serving as anatomic landmarks. Sliding the probe distally or gently tilting the caudal will expose the head of the femur. Returning to the initial starting position, a standard 22 gauge spinal needle is inserted in-plane, from lateral to medial, in the plane between the psoas tendon and the pubic ramus. 20 ml 0.25% bupivacaine diluted with preservative free normal saline then deposited in this plane, lifting the psoas tendon. Care should be taken to avoid puncturing the psoas tendon.

Sponsors

Suez Canal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with hip fracture who will be subjected to surgical treatment * ASA physical status 1, 2

Exclusion criteria

* Patients with chronic pain before surgery (taking opioids). * Patients with multiple trauma * Patients who could not assess pain reliably (dementia). * Substance abuse and prolonged intake of sedative drugs. * Morbid obese patients (BMI\>35). * Patients who have open wounds or infection at the site of the block.

Design outcomes

Primary

MeasureTime frameDescription
The time of first request of analgesia in both groups24 hours postoperativeThe time of first request of analgesia in both groups in minutes

Secondary

MeasureTime frameDescription
difference in Visual Analogue Score (VAS) pain score in the first 24 hours postoperative between the two groupsfirst 24 hours postoperativeVAS pain score from 0-10 while 0 means no pain and 10 means the worst pain, at preparation room, after PENG block, during sitting for spinal anesthesia, at end of surgery, postoperative intervals(rest & movement).
Evaluate the morphine consumption over the first 24 hours.24 hours postoperativetotal dose of morphine in the first hours after surgery
Evaluate the regaining of motor function of quadriceps muscle in both groups24 hours postoperativeEvaluate the motor function of quadriceps muscle by Medical research council (MRC) scale
The incidence of occurrence of side effects related to the technique and medications in both groups24 hours postoperativeNausea, vomiting

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026